GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 Notes to the Consolidated Financial Statements for the year ended March 31, 2022 230 Note 30 : Other income ( ` in lakhs ) Year ended March 31, 2022 Year ended March 31, 2021 Interest income on: Deposits with banks 41,08.67 39,00.37 Income Tax Refund 26,83.54 71,28.52 Loans 3,31.81 16.04 Others 50.49 12.56 Gain on disposal of Property, Plant and Equipment (net) 32.37 - Provision written back 0.67 - Others 3,70.01 0.78 75,77.56 110,58.27 Note 31 : Cost of materials consumed ( ` in lakhs ) Year ended March 31, 2022 Year ended March 31, 2021 Cost of materials consumed 611,17.68 471,78.46 611,17.68 471,78.46 Purchase of stock in trade 729,44.10 823,09.06 729,44.10 823,09.06 Note 32 : Changes in inventories of Finished Goods, Stock-in-Trade and Work-In- Progress ( ` in lakhs ) As at March 31, 2022 As at March 31, 2021 Opening stock Finished goods* 119,89.36 85,80.35 Stock-in-trade 313,38.13 280,02.46 Work-in-progress 1,30.12 30,72.62 434,57.61 396,55.43 Less: Closing stock Finished goods* 145,85.33 119,89.36 Stock-in-trade 272,27.35 313,38.13 Work-in-progress 87.62 1,30.12 419,00.30 434,57.61 15,57.31 (38,02.18) * Finished goods inventory has been adjusted to give effect of discontinued operations (Refer Note 55). Note 33 : Employee benefits expense ( ` in lakhs ) Year ended March 31, 2022 Year ended March 31, 2021 Salaries, wages and bonus 559,17.25 563,60.56 Contributions to : Provident and pension funds (Refer Note 40) 23,14.96 24,51.01 Gratuity funds (Refer Note 40) 8,53.87 8,93.70 Staff welfare expense 19,37.05 19,10.74 610,23.13 616,16.01